Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 17 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 11078286

    Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  2. US 11077178

    Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  3. US 11065327

    Human rotavirus strains and vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  4. US 11066479

    Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  5. US 11066674

    Chimeric antigen receptors targeting b-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted

  6. US 11060110

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  7. US 11058729

    Exosomes and miRNA to treat glaucoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  8. US 11059808

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  9. US 11053314

    Methods to eliminate cancer stem cells by targeting CD47

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  10. US 11052057

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  11. US 11045558

    RPGR gene therapy for retinitis pigmentosa

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  12. US 11040019

    Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  13. US 11041008

    Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  14. US 11041170

    Multivalent vaccines for rabies virus and coronaviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  15. US 11034736

    Anti-viral cnidarins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  16. US 11033621

    Combination therapies targeting tumor-associated stroma or tumor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  17. US 11034740

    Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  18. US 11033620

    Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  19. US 11034757

    Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  20. US 11027008

    Recombinant mumps virus vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  21. US 11026947

    ALK2 inhibitors and methods for inhibiting BMP signaling

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  22. US 11028079

    Small molecule BET bromodomain inhibitors and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  23. US 11028152

    Single domain antibodies to Chikungunya virus

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  24. US 11028444

    Survival predictor for diffuse large B cell lymphoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.